Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $26.54 in the prior trading day, Enovis Corp (NYSE: ENOV) closed at $26.07, down -1.77%. In other words, the price has decreased by -$1.77 from its previous closing price. On the day, 0.77 million shares were traded. ENOV stock price reached its highest trading level at $26.87 during the session, while it also had its lowest trading level at $25.52.
Ratios:
Our goal is to gain a better understanding of ENOV by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 65.48. For the most recent quarter (mrq), Quick Ratio is recorded 1.16 and its Current Ratio is at 2.22. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.69.
Upgrades & Downgrades
In the most recent recommendation for this company, JMP Securities on October 03, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $62.
On June 13, 2024, JP Morgan started tracking the stock assigning a Neutral rating and target price of $53.
On February 13, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $72.Stephens initiated its Overweight rating on February 13, 2024, with a $72 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 09 ’25 when PRYOR DANIEL A sold 999 shares for $27.20 per share. The transaction valued at 27,176 led to the insider holds 0 shares of the business.
PRYOR DANIEL A sold 666 shares of ENOV for $18,122 on Dec 09 ’25. The Former EVP, Strategy & Bus Dev now owns 160,449 shares after completing the transaction at $27.21 per share. On Nov 25 ’25, another insider, KLECKNER JOHN, who serves as the Principal Accounting Officer of the company, bought 2,468 shares for $30.32 each. As a result, the insider paid 74,830 and bolstered with 12,302 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENOV now has a Market Capitalization of 1490927104 and an Enterprise Value of 2901567232. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67 while its Price-to-Book (P/B) ratio in mrq is 0.74. Its current Enterprise Value per Revenue stands at 1.299 whereas that against EBITDA is 7.862.
Stock Price History:
The Beta on a monthly basis for ENOV is 1.29, which has changed by -0.38678372 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, ENOV has reached a high of $49.38, while it has fallen to a 52-week low of $25.47. The 50-Day Moving Average of the stock is -12.88%, while the 200-Day Moving Average is calculated to be -18.17%.
Shares Statistics:
The stock has traded on average 812.64K shares per day over the past 3-months and 947100 shares per day over the last 10 days, according to various share statistics. A total of 57.19M shares are outstanding, with a floating share count of 55.88M. Insiders hold about 2.29% of the company’s shares, while institutions hold 114.56% stake in the company. Shares short for ENOV as of 1764288000 were 8424563 with a Short Ratio of 10.37, compared to 1761868800 on 7722180. Therefore, it implies a Short% of Shares Outstanding of 8424563 and a Short% of Float of 22.14.
Earnings Estimates
Current recommendations for the stock of the company come from 10.0 analysts. The consensus estimate for the next quarter is $0.77, with high estimates of $0.85 and low estimates of $0.63.
Analysts are recommending an EPS of between $3.25 and $3.15 for the fiscal current year, implying an average EPS of $3.19. EPS for the following year is $3.44, with 10.0 analysts recommending between $3.6 and $3.25.
Revenue Estimates
10 analysts predict $585.35M in revenue for. The current quarter. It ranges from a high estimate of $593.73M to a low estimate of $580.4M. As of. The current estimate, Enovis Corp’s year-ago sales were $560.98MFor the next quarter, 10 analysts are estimating revenue of $581.67M. There is a high estimate of $592.77M for the next quarter, whereas the lowest estimate is $566.2M.
A total of 10 analysts have provided revenue estimates for ENOV’s current fiscal year. The highest revenue estimate was $2.27B, while the lowest revenue estimate was $2.25B, resulting in an average revenue estimate of $2.26B. In the same quarter a year ago, actual revenue was $2.11BBased on 10 analysts’ estimates, the company’s revenue will be $2.36B in the next fiscal year. The high estimate is $2.41B and the low estimate is $2.32B.
